• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在或不在?健康状态评估中的收入损失:综述。

In or out? Income losses in health state valuations: a review.

机构信息

School of Health and Related Research, Department of Economics, University of Sheffield, Sheffield, UK.

出版信息

Value Health. 2010 Mar-Apr;13(2):298-305. doi: 10.1111/j.1524-4733.2009.00614.x. Epub 2009 Sep 25.

DOI:10.1111/j.1524-4733.2009.00614.x
PMID:19804433
Abstract

BACKGROUND

In 1996 the Washington Panel controversially recommended valuing productivity costs (PC) in terms of quality-adjusted life years. The Panel's assumption that respondents in health state valuation (HSV) exercises take income losses into account could not be countered since there was no evidence regarding what people consider in HSV exercises. If they do consider income losses and if this changes HSVs, then all economic evaluations that have included PC in the numerator may have double-counted these costs. Alternatively, if respondents do not consider income losses then all past economic evaluations that have not included PC in the numerator have failed to account for sizeable societal costs.

OBJECTIVES

Through a review we aim to recapture the debate surrounding the appropriate method for including PC in health economic evaluations, to identify empirical evidence addressing the assumptions of the Panel, and recommend a future research agenda.

METHODS

Through a review we identify, outline, and critically appraise the existing empirical studies that attempt to address whether respondents include income effects in HSV exercises.

RESULTS AND CONCLUSION

Seven empirical studies were identified. Overall, it seems that not explicitly mentioning the inclusion of income will induce a minority of respondents to include these effects and this appears not to influence results. More empirical work is needed, using generic instruments, larger samples, and using the interview method of administration.

摘要

背景

1996 年,华盛顿小组颇具争议地建议根据质量调整生命年来衡量生产力成本(PC)。小组关于健康状态估值(HSV)练习中的受访者会考虑收入损失的假设无法被反驳,因为没有证据表明人们在 HSV 练习中会考虑哪些因素。如果他们确实考虑了收入损失,并且这会改变 HSV,那么所有包含 PC 作为分子的经济评估可能都已经重复计算了这些成本。或者,如果受访者不考虑收入损失,那么所有过去不包含 PC 作为分子的经济评估都没有考虑到相当大的社会成本。

目的

通过回顾,我们旨在重新探讨将 PC 纳入健康经济评估的适当方法,以确定解决小组假设的经验证据,并为未来的研究议程提供建议。

方法

通过回顾,我们确定、概述和批判性地评价了试图确定受访者是否在 HSV 练习中包含收入效应的现有经验研究。

结果和结论

确定了 7 项经验研究。总体而言,似乎不明确提及收入的包含会促使少数受访者包含这些效应,而且这似乎不会影响结果。需要更多的实证工作,使用通用工具、更大的样本,并采用访谈法进行管理。

相似文献

1
In or out? Income losses in health state valuations: a review.在或不在?健康状态评估中的收入损失:综述。
Value Health. 2010 Mar-Apr;13(2):298-305. doi: 10.1111/j.1524-4733.2009.00614.x. Epub 2009 Sep 25.
2
Does the EQ-5D reflect lost earnings?EQ-5D 反映了收入损失吗?
Pharmacoeconomics. 2012 Jan;30(1):47-61. doi: 10.2165/11539910-000000000-00000.
3
Productivity costs in health-state valuations : does explicit instruction matter?健康状态评估中的生产力成本:明确的指导重要吗?
Pharmacoeconomics. 2006;24(4):401-14. doi: 10.2165/00019053-200624040-00009.
4
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
5
Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises.打破沉默:探讨明确指示对在时间权衡法练习中纳入收入和休闲的潜在影响。
Value Health. 2009 Jan-Feb;12(1):172-80. doi: 10.1111/j.1524-4733.2008.00406.x. Epub 2008 Jul 18.
6
Do the Washington Panel recommendations hold for Europe: investigating the relation between quality of life versus work-status, absenteeism and presenteeism.华盛顿小组的建议对欧洲是否适用:调查生活质量与工作状态、旷工及出勤主义之间的关系。
Cost Eff Resour Alloc. 2014 Nov 24;12:24. doi: 10.1186/1478-7547-12-24. eCollection 2014.
7
Health state valuation in low- and middle-income countries: a systematic review of the literature.中低收入国家的健康状态评估:文献系统综述。
Value Health. 2013 Sep-Oct;16(6):1091-9. doi: 10.1016/j.jval.2013.05.006. Epub 2013 Jul 16.
8
Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations.沉默是金吗?一项关于在健康状态评估中纳入健康不佳对收入和休闲影响的测试。
Health Econ. 2005 Jun;14(6):643-7. doi: 10.1002/hec.971.
9
Inconsistencies in the "societal perspective" on costs of the Panel on Cost-Effectiveness in Health and Medicine.健康与医学成本效益小组在成本“社会视角”方面存在的不一致之处。
Med Decis Making. 1999 Oct-Dec;19(4):371-7. doi: 10.1177/0272989X9901900401.
10
Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis.考虑社会成本能否改变罕见病领域经济评估的推荐?一项实证分析。
Value Health. 2021 Mar;24(3):431-442. doi: 10.1016/j.jval.2020.10.014. Epub 2020 Dec 5.

引用本文的文献

1
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations.将生产率纳入考量以反映治疗价值:已发表的卫生经济评估系统综述
Pharmacoecon Open. 2025 Jun 24. doi: 10.1007/s41669-025-00589-9.
2
Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis.将健康相关生活质量评分与时间利用相关联,以在成本效益分析中为生产力衡量提供信息。
Pharmacoeconomics. 2023 Sep;41(9):1065-1077. doi: 10.1007/s40273-023-01246-x. Epub 2023 Mar 6.
3
Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects.
因旷工和出勤主义导致的生产损失:薪酬机制和乘数效应的影响。
Pharmacoeconomics. 2023 Sep;41(9):1103-1115. doi: 10.1007/s40273-023-01253-y. Epub 2023 Mar 1.
4
Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey.土耳其成人肺炎球菌疾病的间接成本以及基于生产力的13价肺炎球菌结合疫苗对成人的回报率
Hum Vaccin Immunother. 2020 Aug 2;16(8):1923-1936. doi: 10.1080/21645515.2019.1708668. Epub 2020 Jan 29.
5
Future Costs in Cost-Effectiveness Analyses: Past, Present, Future.成本效益分析中的未来成本:过去、现在、未来。
Pharmacoeconomics. 2019 Feb;37(2):119-130. doi: 10.1007/s40273-018-0749-8.
6
A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire.一项关于带状疱疹患者在填写生活质量问卷时对工作和收入损失考量的横断面调查。
BMC Health Serv Res. 2018 Aug 25;18(1):662. doi: 10.1186/s12913-018-3451-9.
7
What were they thinking when providing preference measurements for generic health states? The evidence for HUI3.他们在为通用健康状况提供偏好测量时是怎么想的?HUI3 的证据。
Health Qual Life Outcomes. 2018 Aug 15;16(1):166. doi: 10.1186/s12955-018-0993-9.
8
Association between work time loss and quality of life in patients with Herpes Zoster: a pooled analysis of the MASTER studies.带状疱疹患者工作时间损失与生活质量的关联:MASTER研究的汇总分析
Health Qual Life Outcomes. 2017 Jan 18;15(1):11. doi: 10.1186/s12955-017-0588-x.
9
The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review.疾病成本研究中非正式护理的估值:一项系统综述
Pharmacoeconomics. 2017 Mar;35(3):331-345. doi: 10.1007/s40273-016-0468-y.
10
Cost-effectiveness of spinal manipulative therapy, supervised exercise, and home exercise for older adults with chronic neck pain.脊柱推拿疗法、监督下运动和家庭锻炼对患有慢性颈部疼痛的老年人的成本效益。
Spine J. 2016 Nov;16(11):1292-1304. doi: 10.1016/j.spinee.2016.06.014. Epub 2016 Jun 23.